Man Group
KLRS

Man Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Man Group’s Portfolio KLRS Stock Details KLRS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,702
Closed -$264K – 2293
2022
Q1 		$264K Buy
+1,702
New +$264K ﹤0.01% 1763